Posted on February 9th, 2012 by Health News
Attention-deficit/hyperactivity disorder (ADHD) affects 5-9% of youth and is frequently treated with stimulant medications, such as methylphenidate and amphetamine products. A recent safety communication from the US Food and Drug Administration advised that all patients undergoing ADHD treatment be monitored for changes in heart rate or blood pressure.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Man may not live by bread alone, but cancer in animals appears less resilient, according to a study that found chemotherapy drugs work better when combined with cycles of short, severe fasting.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Sanofi and Bristol-Myers Squibb Company announced today that Apotex has made payment in the amount of $442,209,362 to Sanofi and Bristol-Myers Squibb to satisfy the damages ruling of the Plavix (clopidogrel bisulfate) patent infringement case against Apotex.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Scientists at Indiana University, Methodist Research Institute study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor model, appear online in The International Journal of Oncology.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
There is growing evidence that supports an association between atypical fractures of the femur- a rare break of the thigh bone, typically without trauma - and the use of bisphosphonates, drugs proven to enhance bone density and reduce fracture incidence caused by osteoporosis.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has reached a settlement with Janssen Pharmaceuticals, Inc. on outstanding patent litigation related to Watson’s generic version of Janssen’s ORTHO TRI-CYCLEN LO (norgestimate/ethinyl estradiol) tablets.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Although some data have suggested a possible increased risk of intussusception (when a portion of the small or large intestine slides forward into itself, like a telescope) after administration of the pentavalent rotavirus vaccine in infants, an analysis that included almost 800,000 doses administered to U.S. infants found no increased risk of this condition following vaccination, according to a study in the February 8 issue of JAMA.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
In this post in the Guardian’s “The Observer,” Mark Honigsbaum, a research associate at the University of Zurich’s Institute for Medical History, interviews Peter Seeberger, the director of the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, about a recent announcement that Seeberger and colleague François Lévesque “have discovered a simple and cost-effective way of synthesizing artemisinin from the waste products of the” sweet wormwood plant from which it is extracted.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.
Read more…
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Edward Mills of the University of Ottawa, Canada and colleagues argue in this week’s PLoS Medicine that the HIV/AIDS response in Africa needs a more balanced approach to gender, so that both men and women are involved in HIV treatment and prevention…
Read more…
Filed under: Men's Health
